Cargando…

AZGP1 Protein Expression in Hormone-Naïve Advanced Prostate Cancer Treated with Primary Androgen Deprivation Therapy

Biomarkers for predicting the risk of castration-resistant prostate cancer (CRPC) in men treated with primary androgen deprivation therapy (ADT) are lacking. We investigated whether Zinc-alpha 2 glycoprotein (AZGP1) expression in the diagnostic biopsies of men with hormone-naïve prostate cancer (PCa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Winther, Mads Dochedahl, Kristensen, Gitte, Stroomberg, Hein Vincent, Berg, Kasper Drimer, Toft, Birgitte Grønkær, Brooks, James D., Brasso, Klaus, Røder, Martin Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460336/ https://www.ncbi.nlm.nih.gov/pubmed/32726925 http://dx.doi.org/10.3390/diagnostics10080520

Ejemplares similares

The Association between Plasma Levels of Intact and Cleaved uPAR Levels and the Risk of Biochemical Recurrence after Radical Prostatectomy for Prostate Cancer
por: Stroomberg, Hein Vincent, et al.
Publicado: (2020)

5hmC Level Predicts Biochemical Failure Following Radical Prostatectomy in Prostate Cancer Patients with ERG Negative Tumors
por: Kristensen, Gitte, et al.
Publicado: (2019)

Diagnostic Age, Age at Death and Stage Migration in Men Dying with or from Prostate Cancer in Denmark
por: Andersen, Marc Casper Meineche, et al.
Publicado: (2022)

Novel functions of the luteinizing hormone/chorionic gonadotropin receptor in prostate cancer cells and patients
por: Stroomberg, Hein Vincent, et al.
Publicado: (2020)

Validation of the four-miRNA biomarker panel MiCaP for prediction of long-term prostate cancer outcome
por: Strand, Siri H., et al.
Publicado: (2020)

Danish Prostate Registry (DanProst) – an Updated Version of the Danish Prostate Cancer Registry, Methodology, and Early Results
por: Stroomberg, Hein Vincent, et al.
Publicado: (2023)

Risk of prostate cancer and death after benign transurethral resection of the prostate—A 20‐year population‐based analysis
por: Hilscher, Maria, et al.
Publicado: (2022)

Impact of androgen deprivation therapy on the thymus and the production of naïve T-cells
por: Madan, Ravi A, et al.
Publicado: (2013)

Effects of acute exercise training on tumor outcomes in men with localized prostate cancer: A randomized controlled trial
por: Djurhuus, Sissal Sigmundsdóttir, et al.
Publicado: (2022)

AZGP1 inhibits soft tissue sarcoma cells invasion and migration
por: Liu, Jiayong, et al.
Publicado: (2018)

Efficacy of dexamethasone in reducing the postembolisation syndrome in men undergoing prostatic artery embolisation for benign prostatic hyperplasia: protocol for a single-centre, randomised, double-blind, placebo-controlled trial—the ‘DEXAPAE’ study
por: Svarc, Petra, et al.
Publicado: (2021)

Exercise training to increase tumour natural killer‐cell infiltration in men with localised prostate cancer: a randomised controlled trial
por: Djurhuus, Sissal Sigmundsdóttir, et al.
Publicado: (2022)

Decreased Expression of AZGP1 Is Associated with Poor Prognosis in Primary Gastric Cancer
por: Huang, Chun-yu, et al.
Publicado: (2013)

The Therapeutic Potential of Zinc-Alpha2-Glycoprotein (AZGP1) in Fibrotic Kidney Disease
por: Sörensen-Zender, Inga, et al.
Publicado: (2022)

First Danish Single-Institution Experience with Radical Prostatectomy: Biochemical Outcome in 1200 Consecutive Patients
por: Røder, M. Andreas, et al.
Publicado: (2011)

Efficacy of abiraterone acetate for high-risk hormone-naïve metastatic prostate cancer: A comparison with combined androgen blockade therapy with bicalutamide and androgen deprivation therapy alone
por: Kanao, Kent, et al.
Publicado: (2022)

The Importance of Time to Prostate-Specific Antigen (PSA) Nadir after Primary Androgen Deprivation Therapy in Hormone-Naïve Prostate Cancer Patients
por: Sasaki, Takeshi, et al.
Publicado: (2018)

Changes in AZGP1 Serum Levels and Correlation With Pulse Wave Velocity After Kidney Transplantation
por: Kraemer, Thomas Daniel, et al.
Publicado: (2021)

AZGP1 Up-Regulation is a Potential Target for Andrographolide Reversing Radioresistance of Colorectal Cancer
por: Fang, Ye-Ying, et al.
Publicado: (2022)

Consultation on urological specimens from referred cancer patients using real-time digital microscopy: Optimizing the workflow
por: Holten-Rossing, Henrik, et al.
Publicado: (2016)

Reduction of AZGP1 predicts poor prognosis in esophageal squamous cell carcinoma patients in Northern China
por: Tang, Hong, et al.
Publicado: (2016)

Development of a prediction model for mortality and cardiovascular outcomes in older adults taking into account AZGP1
por: Huscher, Dörte, et al.
Publicado: (2021)

Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy
por: Stensland, Kristian D, et al.
Publicado: (2022)

Incidence of and Risk Factors for Recurrent Urinary Tract Infections in Renal Transplant Recipients
por: Halskov, Anna C.L., et al.
Publicado: (2023)

The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment
por: Ku, Ja Yoon, et al.
Publicado: (2015)

Luteinizing Hormone Receptor Is Expressed in Testicular Germ Cell Tumors: Possible Implications for Tumor Growth and Prognosis
por: Lorenzen, Mette, et al.
Publicado: (2020)

Genotype–phenotype associations in PPGLs in 59 patients with variants in SDHX genes
por: Main, Ailsa Maria, et al.
Publicado: (2020)

Androgen deprivation and cognition in prostate cancer
por: Salminen, E, et al.
Publicado: (2003)

Androgen Deprivation Therapy and Cardiovascular Risk
por: Mourmouris, Panagiotis, et al.
Publicado: (2012)

Metabolic effects of androgen deprivation therapy
por: Choi, See Min, et al.
Publicado: (2015)

Cardiovascular Toxicities of Androgen Deprivation Therapy
por: Challa, Azariyas A., et al.
Publicado: (2021)

CARDIOVASCULAR DISEASES AND ANDROGEN DEPRIVATION THERAPY
por: Boban, Marko
Publicado: (2019)

Cardiovascular Toxicity of Androgen Deprivation Therapy
por: Boland, Julia, et al.
Publicado: (2021)

Postembolization Syndrome after Prostatic Artery Embolization: A Systematic Review
por: Svarc, Petra, et al.
Publicado: (2020)

Characteristics of Patients in SPCG-15—A Randomized Trial Comparing Radical Prostatectomy with Primary Radiotherapy plus Androgen Deprivation Therapy in Men with Locally Advanced Prostate Cancer
por: Gongora, Magdalena, et al.
Publicado: (2022)

Long non-coding RNA00844 inhibits MAPK signaling to suppress the progression of hepatocellular carcinoma by targeting AZGP1
por: Lin, Bingyi, et al.
Publicado: (2020)

The prognostic value of immune-related genes AZGP1, SLCO5A1, and CTF1 in Uveal melanoma
por: Wang, Wanpeng, et al.
Publicado: (2022)

Down Regulation of EGF and AZGP1 Were Associated with Clinical Characteristics in Chronic Rhinosinusitis with Nasal Polyps: An Observation Study
por: Jin, Peng, et al.
Publicado: (2023)

Danish Prostate Cancer Registry – methodology and early results from a novel national database
por: Helgstrand, JT, et al.
Publicado: (2016)

Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
por: Chen, Mengqian, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_fmatcmuersg7fdfp7i95jfq67r